Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine

Angiogenesis is one of the hallmarks of cancer. Several studies have shown that vascular endothelium growth factor (VEGF) plays a leading role in angiogenesis progression. Antiangiogenic medication has gained substantial recognition and is commonly administered in many forms of human cancer, leading...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsaab, Hashem O., Al-Hibs, Alanoud S., Alzhrani, Rami, Alrabighi, Khawlah K., Alqathama, Aljawharah, Alwithenani, Akram, Almalki, Atiah H., Althobaiti, Yusuf S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915670/
https://www.ncbi.nlm.nih.gov/pubmed/33562829
http://dx.doi.org/10.3390/ijms22041631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915670/
https://www.ncbi.nlm.nih.gov/pubmed/33562829
http://dx.doi.org/10.3390/ijms22041631

Ejemplares similares